RVCL - Retinal Vasculopathy Cerebral Leukoencephalopathy

Clinical trial pipeline · Data from ClinicalTrials.gov

See which RVCL - Retinal Vasculopathy Cerebral Leukoencephalopathy trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedPhase 2

NCT04611880

Crizanlizumab for Treatment of Retinal Vasculopathy With Cerebral Leukoencephalopathy (RVCL)

This is a Phase 2 trial that will test the efficacy and safety of crizanlizumab for the treatment of retinal vasculopathy with cerebral leukoencephalopathy (RVC…

United States18 participantsStarted 2021-01-25

Treatment: Crizanlizumab